CVRx IncNASDAQ:CVRX
- LAST PRICE15.0500
- TODAY'S CHANGE (%)-0.4800 (-3.0908%)
- Bid / Lots15.0700/ 1
- Ask / Lots15.1800/ 7
- Open / Previous Close15.5500 / 15.5300
- Day Range
- 52 Week Range
- Volume31,295
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | CVRX |
|---|---|---|
| 09:32 ET | 3366 | 15.55 |
| 09:33 ET | 200 | 15.32 |
| 09:35 ET | 1096 | 15.08 |
| 09:42 ET | 700 | 15.06 |
| 09:44 ET | 100 | 15.33 |
| 09:46 ET | 300 | 15.12 |
| 09:50 ET | 200 | 15.33 |
| 09:51 ET | 401 | 15.33 |
| 09:55 ET | 100 | 15.555 |
| 10:09 ET | 100 | 15.275 |
| 10:11 ET | 2586 | 15.47 |
| 10:13 ET | 500 | 15.375 |
| 10:18 ET | 200 | 15.22 |
| 10:22 ET | 15574 | 14.86 |
| 10:24 ET | 400 | 15.05 |
| 10:26 ET | 150 | 15.05 |
Nov 20, 2024
CVRx to Present at the Piper Sandler 36th Annual Healthcare Conference, from 4:30PM ET on Wednesday Nov 20, 2024 by Dow Jones
4:30PM ET on Wednesday Nov 20, 2024 by Dow Jones
Nov 4, 2024
DJ CVRx Is Maintained at Buy by Craig-Hallum, from 12:36PM ET on Monday Nov 04, 2024 by Dow Jones
12:36PM ET on Monday Nov 04, 2024 by Dow JonesCVRx Announces Positive Outpatient Payment for Barostim Procedure in 2025, from 8:00AM ET on Monday Nov 04, 2024 by Dow Jones
8:00AM ET on Monday Nov 04, 2024 by Dow Jones
Oct 30, 2024
DJ CVRx Is Maintained at Buy by Lake Street, from 2:39PM ET on Wednesday Oct 30, 2024 by Dow Jones
2:39PM ET on Wednesday Oct 30, 2024 by Dow JonesDJ CVRx Is Maintained at Buy by Canaccord Genuity, from 1:38PM ET on Wednesday Oct 30, 2024 by Dow Jones
1:38PM ET on Wednesday Oct 30, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
CVRx Inc | 360.3M | -5.6x | --- |
Alpha Teknova Inc | 390.7M | -9.1x | --- |
Delcath Systems Inc | 312.1M | -7.6x | --- |
Pulmonx Corp | 268.1M | -4.4x | --- |
Semler Scientific Inc | 462.5M | 28.5x | +31.99% |
Utah Medical Products Inc | 221.4M | 15.2x | +2.27% |
Company Information
CVRx, Inc. is a commercial-stage medical device company. The Company is focused on developing, manufacturing and commercializing advanced neuromodulation solutions for patients with cardiovascular diseases. The Company's integrated platform technology, Barostim, is designed to leverage the power of the brain and nervous system to address the imbalance of the autonomic nervous system (ANS), which causes heart failure with reduced ejection fraction (HFrEF) and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy (BAT) by sending imperceptible and persistent electrical pulses to baroreceptors located in the wall of the carotid artery to signal the brain to modulate cardiovascular function. Barostim is a minimally invasive neuromodulation device that consists of two implantable components, an implantable pulse generator (IPG) and a stimulation lead, and is programed by a wireless clinician-controlled programmer that communicates with the IPG.
Contact Information
- Headquarters
- 9201 West Broadway Avenue, Suite 650MINNEAPOLIS, MN, United States 55445
- Phone
- 763-416-2850
- Fax
- 763-416-2841
Executives
- President, Chief Executive Officer, Director
- Kevin Hykes
- Chief Financial Officer
- Jared Oasheim
- Senior Vice President - US Sales
- Craig Palmer
- Senior Vice President - Global Clinical Affairs
- Jennifer Englund
- Senior Vice President - Patient Access, Reimbursement, and Health Care Economics
- Bonnie Handke
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $360.3M |
|---|---|
Revenue (TTM) | $47.3M |
Shares Outstanding | 24.3M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.16 |
EPS | $-2.71 |
Book Value | $3.64 |
P/E Ratio | -5.6x |
Price/Sales (TTM) | 7.6 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -124.59% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
